investment & stocks ideas
investment & stocks ideas
Favourites   Have ideas?  Sign in / Register

Positive:   Disease: Infectious ↓4.9   Covid (fighting) ↓4.9   Food ↓4.9 «See more»   Devices ↑3.52   Pharmaceutical  ↑4.03   Disease: Liver ↑5.1

Life Sciences stock segment: trending tickers

ACTG Acacia Research Corporation - Common Stock 0.82% up -0.27% 1.09 + Acquisitions/Investing, Technology, Life Sciences, Finance

Last highlighted: 10-Q Sec report https://www.sec.gov/Archives/edgar/data/934549/000093454923000100/0000934549-23-000100-index.htm
10-Q - ACACIA RESEARCH CORP (0000934549) (Filer)
+ My List
ATNFW 180 Life Sciences Corp. - Warrant 0.00% 0 + Life Sciences, Medicine
+ My List
IDXG Interpace Biosciences, Inc. - Common Stock -1.59% -1.59% 0 + Medicine, Disease: Oncology, Cancer fight, Life Sciences

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1054102/000149315223039945/0001493152-23-039945-index.htm
8-K - INTERPACE BIOSCIENCES, INC. (0001054102) (Filer)
+ My List
LFVN Lifevantage Corporation - Common Stock 0.16% down 0.79% -0.63 + Healthcare, Life Sciences, 1% Dividends

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/849146/000084914623000208/0000849146-23-000208-index.htm
8-K/A - Lifevantage Corp (0000849146) (Filer)
+ My List
NDRA ENDRA Life Sciences Inc. - Common Stock 5.10% up 0.00% 5.1 + Life Sciences, Disease: Liver

Last highlighted: 10-Q Sec report https://www.sec.gov/Archives/edgar/data/1681682/000165495423014357/0001654954-23-014357-index.htm
10-Q - ENDRA Life Sciences Inc. (0001681682) (Filer)
+ My List
OPRX OptimizeRx Corporation - Common Stock 0.95% up 0.53% 0.42 + Healthcare, Life Sciences, SaaS

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1448431/000121390023083645/0001213900-23-083645-index.htm
8-K - OptimizeRx Corp (0001448431) (Filer)
+ My List
RSSS Research Solutions, Inc - Common Stock 4.03% up 2.42% 1.61 + Life Sciences, SaaS, Pharmaceutical

Last highlighted: 10-Q Sec report https://www.sec.gov/Archives/edgar/data/1305168/000130516823000101/0001305168-23-000101-index.htm
10-Q - ARC DOCUMENT SOLUTIONS, INC. (0001305168) (Filer)
+ My List
TOMZ TOMI Environmental Solutions, Inc. - Common Stock -4.90% -4.90% 0 + Disease: Infectious, Medicine, Equipment, Life Sciences, Food, Covid (fighting)

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/314227/000165495423014366/0001654954-23-014366-index.htm
8-K - TOMI Environmental Solutions, Inc. (0000314227) (Filer)
+ My List
WVE Wave Life Sciences Ltd. - Ordinary Shares 1.32% up 1.13% 0.19 + Medicine, Biotechnology, Life Sciences

Last highlighted: 10-Q Sec report https://www.sec.gov/Archives/edgar/data/1631574/000095017023061544/0000950170-23-061544-index.htm
10-Q - Wave Life Sciences Ltd. (0001631574) (Filer)
+ My List
XGN Exagen Inc. - Common Stock -4.79% down -1.06% -3.73 + Life Sciences, Medicine, Immunology

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1274737/000127473723000105/0001274737-23-000105-index.htm
8-K - EXAGEN INC. (0001274737) (Filer)
+ My List
MASS 908 Devices Inc. - Common Stock 3.52% up -3.02% 6.54 + Devices, Biopharma, Life Sciences

Last highlighted: 10-Q Sec report https://www.sec.gov/Archives/edgar/data/1555279/000155837023017879/0001558370-23-017879-index.htm
10-Q - 908 Devices Inc. (0001555279) (Filer)
+ My List
VINC Vincerx Pharma, Inc. - Common Stock -6.15% down -4.62% -1.53 + Biopharma, Medicine, Life Sciences

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1796129/000119312523276707/0001193125-23-276707-index.htm
8-K - Vincerx Pharma, Inc. (0001796129) (Filer)
+ My List
ALPP Alpine 4 Holdings, Inc. - Class A Common Stock -2.35% up -4.71% 2.36 + Acquisitions/Investing, Life Sciences

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1606698/000162828023039894/0001628280-23-039894-index.htm
8-K - ALPINE 4 HOLDINGS, INC. (0001606698) (Filer)
+ My List


We do not provide financial advice. All displayed data is the result of experiments, and a subjective assessment. All decisions that will be made based on this data are made at your own risk. Thank you for understanding.